Skip to main content

Table 2 Summary of body weights, body weight changes, and food consumption during 14-day treatment-free recovery period

From: Pharmacokinetics, radiation dosimetry, acute toxicity and automated synthesis of [18F]AmBF3-TATE

GroupDose (mg/kg)Mean body weight (g) ± SDBody weight changes (g) ± SD Days 1–14 (n = 5)Mean food consumption (g) ± SD Days 1–14 (n = 5)
Day 1 (n = 15)Day 2 (n = 10)Day 8 (n = 5)Day 14 (n = 5)
1-F0212.3 ± 11.4197.0 ± 10.9232.4 ± 10.5242.2 ± 13.2+ 30.2 ± 8.9230.6 ± 15.4
2-F0.742212.2 ± 13.6195.4 ± 11.3227.1 ± 23.6240.9 ± 19.7+ 29.3 ± 4.7229.8 ± 16.9
1-M0295.5 ± 15.0265.8 ± 14.1359.7 ± 14.7403.2 ± 21.1+ 108.1 ± 14.8404.0 ± 32.3
2-M0.742297.2 ± 17.2265.4 ± 13.5358.0 ± 21.1388.5 ± 16.1+ 86.6 ± 11.5*365.7 ± 19.4
  1. *Significantly different from control group (p < 0.05)